In a 5-FU-resistant HER2-positive colorectal cancer mouse model, co-delivery of an miR-21 inhibitor using EVs decorated with a LAMP2-HER2 affibody fusion significantly enhanced cytotoxicity and restored 5-FU sensitivity (79). This evidence concerns the gene ERBB2 and colorectal cancer.